Author Question: The major advantage of chorionic villus sampling over amniocentesis is that it: a. is not an ... (Read 101 times)

nmorano1

  • Hero Member
  • *****
  • Posts: 598
The major advantage of chorionic villus sampling over amniocentesis is that it:
 
  a. is not an invasive procedure.
  b. does not require hospitalization.
  c. has less risk of spontaneous abortion.
  d. requires less time to obtain results.

Question 2

Which nursing intervention is necessary prior to a second trimester transabdominal ultrasound?
 
  a. Ensure the client is NPO for 12 hours.
  b. Instruct the client to drink 1 to 2 quarts of water.
  c. Administer a soap suds enema.
  d. Perform an abdominal prep.



tranoy

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

D
Results from chorionic villus sampling can be known within 24 to 48 hours, whereas results from amniocentesis require 2 to 4 weeks.

Answer to Question 2

B
When the uterus is still in the pelvis, visualization may be difficult. It is necessary to perform the test when the woman has a full bladder, which provides a window through which the uterus and its contents can be viewed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library